![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/656780a484a6aa6c15885afd_homepage%20hero%20bg%20png.webp)
OncoHost is advancing a new paradigm in precision oncology
Our PROphet® platform combines bioinformatics, system biology, proteomic pattern recognition and machine learning to assign a PROphet® score, a measure of the predicted clinical benefit from
PD-1/PD-L1 inhibitors correlated to the patient’s overall survival, and list clinical evidence-based treatment considerations.
Understanding the interplay between
Cancer, Patient & Therapy
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/64f48f546ef461a95ebe9f2d_image-1.webp)
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/658866897efa8f5563f4bd11_lightbox%20i%20thumbnail.jpg)
A new dimension to personalization
Watch now
A new approach to managing PD-1/PD-L1 inhibitor therapeutic strategies
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/6562eb1b332c7603e8b8105d_new%20approach%20icon%201.webp)
Blood-based test
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/6562eb1c2f3bb75b0b7b607e_new%20approach%20icon%202.webp)
Personalized
PROphet® Report
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/6562eb1c134c5c08c0050618_new%20approach%20icon%203.webp)
Predictive
clinical insights
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/6562eb1b7bcf718b80c9a5cf_new%20approach%20icon%204.webp)
Clinical evidence-
based treatment considerations
![](https://cdn.prod.website-files.com/64f46e516ef461a95ea513b4/64f48f556ef461a95ebe9f94_image-6.webp)
Plasma Proteomic
Pattern Recognition
Analyzing the biological interplay between the patient, tumor, and therapy can:
Enable early prediction of clinical benefit from PD-1/PD-L1 inhibitors
Provide actionable clinical insights and optimal therapy choices
Read more